pembrolizumab,lenvatinib
merck,eisai
['lenva', 'rcc,(-irccs),(-srcc),(-urcc)', 'pembro']
exciting results in 1st line advanced nccrcc! orr and dcr under lenva+pembro: 47% and 79% by #esmo22 disappointing in chrcc orr: 13% 
Medical oncologist - Views my own.